The combined expression of sterol regulatory element-binding protein 2 (SREBP2) together with HMGCR, NR1H3, and NR1H2 genes was associated with poor CRC clinical outcome independent of lymph node metastasis, distant metastasis, and advanced stage (156). Here, SREBF2 is linked to metastatic malignant neoplasm in the lymph nodes.